Dik C. van Gent

Erasmus University Rotterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

Nienke D. Sijtsema

Erasmus University Rotterdam

NETHERLANDS

View details

Wai Leong Tam

Associate Professor (Adjunct)

National University Singapore Yong Loo Lin School of Medicine

SINGAPORE

View details

NITIKA TANEJA

Associate Professor

Erasmus MC

NETHERLANDS

View details

Yu-Hsiu Wang

Research Assistant Professor

University of Texas Medical Branch

UNITED STATES

View details

Wilma Heemsbergen

Erasmus University Rotterdam

NETHERLANDS

View details

Stijn Keereweer

university medical center rotterdam

NETHERLANDS

View details

jose angelito hardillo

Head and neck surgeon

Erasmus University Medical Center

NETHERLANDS

View details

Wytske M. van Weerden

Erasmus University Medical Center

NETHERLANDS

View details

Chiara Diquigiovanni

Jr. Assistant Professor

University of Bologna

ITALY

View details

Elena Bonora

Associate Professor

University of Bologna

ITALY

View details

Brita Singers Sørensen

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dik C. van Gent

Research Interests

Explore related searches

Contact this professor

Articles (14)

Development of an Ex Vivo Functional Assay for Prediction of Irradiation Related Toxicity in Healthy Oral Mucosa Tissue

Ex vivo radiation sensitivity assessment for individual head and neck cancer patients using deep learning-based automated nuclei and DNA damage foci detection

Functional Homologous Recombination (HR) Screening Shows the Majority of <i>BRCA1/2</i>-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient

Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response

Ex Vivo Functional Assay for Evaluating Treatment Response in Tumor Tissue of Head and Neck Squamous Cell Carcinoma

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients

A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture

Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests

The COMPLETE trial

Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer

Biallelic variants in LIG3 cause a novel mitochondrial neurogastrointestinal encephalomyopathy

A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair

Collaborators (11)

Nienke D. Sijtsema

Wai Leong Tam

NITIKA TANEJA

Yu-Hsiu Wang

Wilma Heemsbergen

Stijn Keereweer

jose angelito hardillo

Wytske M. van Weerden

Chiara Diquigiovanni

Elena Bonora

Brita Singers Sørensen

Make your next move.